Invitation to Workshop on Pharmas Use of Grids

Forwarding this to the group... 


Invitation to Workshop on Pharmas Use of Grids

 
When: January 30, 2007, 2 PM
 
Where: At Open Grid Forum 19, UNC Chapel Hill Friday Center, 100 Friday Center Drive
Chapel Hill, NC 27599
(919) 962-3000
www.fridaycenter.unc.edu <http://www.fridaycenter.unc.edu/>  
 
Duration: 90 minutes. There is a standards orientation presentation at 8 AM that will provide a broad overview of OGF's efforts.
 
Format: A roundtable discussion where participants raise issues and have time to discuss the details and situation when such issues arise. No formal presentations. Effort will be made to focus on two-three priority issues and to offer enough detail to illustrate the context when the issues arise.
 
 
Purpose: To discuss how pharma firms are using Grids and the main issues they have will Grids. This effort is to identify specific issues that can be addressed by the Open Grid Forum's Technology Standards Group and the various Working Groups of OGF. The hope is that by identifying these issues, end-users can help the OGF focus on end-user needs and speed work on standards that help pharma firms use Grids more effectively.
 
Agenda: To review points made at the Pharma and Grid Workshop Washington meeting in September (see attached summary). To provide more specificity on the issues raised, i.e., to fill in more details about when the issues arise, in what context, while using what applications, and in what types of processing and use of data. This would place the issues squarely in an understandable context and help get OGF action going.
 
 
Invitees: The participants in the Washington review (Alex L. Bangs of Entelos, John Saalwaechter of Lilly, Timothy Wagner of BMS, Jeff Mathers of J&J, and Sanjoy Ray of Merck). Others in the industry will also be invited. These people include Peter S. Shenkin of Schrodinger, Robin deMent and Alex Roses of GSK, Stephen Perrenod of Exludus, Carol Hamilton of Paragen, Todd Fuqua of Sphinx (Lilly), Max Wallace of Cogent Neurogenetics, Dean F. Bushey of BayerCropScience, Mark Dibner of BioAbility, Scot Huber of
Scynexis, Blaze Stancampiano, Charles Jaffe, and Otto Ritter of AstraZeneca, Abdelazize Laoui of Sanofi-Aventis, Chris Dagdigian of The BioTeam, Jim Golden and John Murphy of CuraGen, Jonathan McIntyre of Monsanto, Sam Yenne of Paradigm Genetics, Chris Woodward of Targacept, and others.
 
 
RSVP: Bob Cohen, Area Director, Industrial Applications, OGF. bcohen@bway.net <mailto:bcohen@bway.net>  or 917-705-6524.  





Eric Neumann, PhD
co-chair, W3C Healthcare and Life Sciences,
and Senior Director Product Strategy
Teranode Corporation
411 1st Avenue South, Suite 700
Seattle, WA 98104
+1 (781)856-9132
www.teranode.com